Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;87(9):848-52.
doi: 10.1002/ajh.23262. Epub 2012 Jun 5.

Prevalence of primary immune thrombocytopenia in Oklahoma

Deirdra R Terrell  1 , Laura A Beebe, Barbara R Neas, Sara K Vesely, Jodi B Segal, James N George
Affiliations

Prevalence of primary immune thrombocytopenia in Oklahoma

Deirdra R Terrell et al. Am J Hematol. 2012 Sep.

Abstract

To determine the prevalence of immune thrombocytopenia (ITP) in Oklahoma regardless of age, clinical characteristics, insurance status, and source of health care. Patients with ITP were identified by the administrative code ICD-9-CM 287.3 in Oklahoma hematologists' offices for a 2-year period, 2003-2004. Prevalence was estimated separately for children (<16 years old) and adults because of their distinct clinical characteristics. Oklahoma census data for 2000 was used as the denominator. Eighty-seven (94%) of 93 eligible Oklahoma hematologists participated; 620 patients with ITP were identified. The average annual prevalences were as follows: 8.1 (95% CI: 6.7-9.5) per 100,000 children, 12.1 (95% CI: 11.1-13.0) per 100,000 adults, and 11.2 (95% CI: 10.4-12.0) per 100,000 population. Among children and adults less than age 70 years, the prevalence was greater among women. Among adults aged 70 years and older, the prevalence was greater among men. The highest prevalence of ITP was among men age 80 years and older. These data document for the first time the prevalence of ITP regardless of age, clinical characteristics, insurance status, and source of health care. The methodology developed for this prevalence analysis may be adaptable for epidemiologic studies of other uncommon disorders which lack specific diagnostic criteria and are treated primarily by medical specialists. Am. J. Hematol. 2012. © 2012 Wiley Periodicals, Inc.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest with the data or subject of this manuscript.

Figures

Figure 1
Figure 1
Figure 1a. ITP Gender and Age-Specific Prevalence, Oklahoma Figure 1b.
Figure 1
Figure 1
Figure 1a. ITP Gender and Age-Specific Prevalence, Oklahoma Figure 1b.
See this image and copyright information in PMC

Comment in

References

    1. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions, and outcome criteria in immune thrombocytopenic purpura (ITP) in adults and children. Report from an international working group. Blood. 2009;113:2386–93. - PubMed
    1. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs PHB, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–86. - PubMed
    1. Neunert CE, Lim W, Crowther MA, Cohen AR, Solberg LA, Jr, Crowther M. The American Society of Hematology 2011 evidenced-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190–4207. - PubMed
    1. Portielje JEA, Westendorp RGJ, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001;97:2549–54. - PubMed
    1. Neylon AJ, Saunders PWG, Howard MR, Proctor SJ, Taylor PRA. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol. 2003;122:966–74. - PubMed

Publication types